Covista director Stephen Beard proposes $474K sale
The proposed sale is linked to a selling plan dated December 10, 2025, intended to comply with Rule 10b5-1(c).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Covista Inc. director Stephen Beard reported a proposed sale of 3,639 common shares, with an aggregate market value of $474,125.31 and an approximate sale date of October 8, 2026. Goldman Sachs & Co. LLC is listed as the broker, and NYSE as the exchange. The shares are to be sold from the Stephen Wayne Beard Trust; the related trust entry names Stephen W. Beard Jr. as trustee. The sale is connected to a selling plan dated December 10, 2025, intended to comply with Rule 10b5-1(c). The shares were acquired as compensation through restricted stock units on September 8, 2025. In the past three months, the trust's reported sales were 5,291 shares for $702,399.3 on July 13, 2026, and 3,545 shares for $462,073.73 on August 11, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Rule 10b5-1(c) regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sales by the CVSA trust were listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.